• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌相关微生物组的特征。

Characterization of disease-associated microbiota in hepatocellular carcinoma.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Shandong Cancer Hospital and Institute, Shandong Fist Medical University and Shandong Academy of Medical Sciences, Jinan City, Shandong Province, China.

出版信息

J Cancer Res Ther. 2023 Aug;19(4):881-891. doi: 10.4103/jcrt.jcrt_139_22.

DOI:10.4103/jcrt.jcrt_139_22
PMID:37675712
Abstract

AIMS

This study aimed to investigate the differences in the composition of microbial communities and related functions in hepatocellular carcinoma (HCC) tumours and matched normal tissues were investigated.

METHODS AND MATERIAL

Tumour tissues and matched normal samples were collected from 30 HCC patients. Genomic DNA was collected and subjected to sequencing of the V3 + V4 region of the 16S rRNA gene. The microbial community profiles and metabolic pathway predictions of the different groups were characterized and compared.

RESULTS

Tumour and adjacent tissues had similar microbiota compositions but differed in abundance. Proteobacteria and Firmicutes abundance decreased and Cyanobacteria and Acidobacteria abundance increased in the tumour tissue. The microbial community diversity was higher in the tumour tissues than in adjacent samples, with potentially more dominant taxa in the adjacent tissues, including Firmicutes, Proteobacteria, and Actinobacteria. Acidobacteria, Cyanobacteria, and Chloroflexi were the dominant microbes in tumour tissues. A total of 46 metabolic pathways were identified. Global and overview maps were the most abundant pathways, followed by carbohydrate metabolism, energy metabolism, metabolism of cofactors and vitamins, and membrane transport. The top 50 most highly correlated microbial genera included Klebsiella, Rhodococcus, Ochrobactrum, and Azoarcus. Fonticella, Haloimpatiens, Brevibacterium, and Acidothermus were positively correlated with other microbial genera. The microbiota of adjacent tissues was more robust in the network analysis.

CONCLUSIONS

This study revealed differences in microbial composition between HCC tumour tissues and normal tissues and differences in microbial abundance associated with different metabolic functions. Cyanobacteria, Proteobacteria, and Actinobacteria may play important roles in HCC.

摘要

目的

本研究旨在探讨肝细胞癌(HCC)肿瘤组织与匹配的正常组织中微生物群落组成及相关功能的差异。

方法与材料

收集了 30 例 HCC 患者的肿瘤组织和匹配的正常样本。提取基因组 DNA,进行 16S rRNA 基因 V3+V4 区测序。对不同组的微生物群落谱和代谢途径预测进行了特征化和比较。

结果

肿瘤和相邻组织具有相似的微生物群落组成,但丰度不同。肿瘤组织中变形菌门和厚壁菌门的丰度降低,蓝细菌门和酸杆菌门的丰度增加。肿瘤组织中的微生物群落多样性高于相邻样本,相邻组织中可能具有更多的优势菌群,包括厚壁菌门、变形菌门和放线菌门。酸杆菌门、蓝细菌门和绿弯菌门是肿瘤组织中的主要微生物。共鉴定出 46 条代谢途径。全局和概览图谱是最丰富的途径,其次是碳水化合物代谢、能量代谢、辅因子和维生素代谢以及膜转运。前 50 个相关性最高的微生物属包括克雷伯氏菌属、红球菌属、弧菌属和固氮菌属。Fonticella、Haloimpatiens、Brevibacterium 和 Acidothermus 与其他微生物属呈正相关。网络分析中相邻组织的微生物群更为稳健。

结论

本研究揭示了 HCC 肿瘤组织与正常组织之间微生物组成的差异以及与不同代谢功能相关的微生物丰度的差异。蓝细菌门、变形菌门和放线菌门可能在 HCC 中发挥重要作用。

相似文献

1
Characterization of disease-associated microbiota in hepatocellular carcinoma.肝癌相关微生物组的特征。
J Cancer Res Ther. 2023 Aug;19(4):881-891. doi: 10.4103/jcrt.jcrt_139_22.
2
Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.二乙基亚硝胺诱导原发性肝癌小鼠的肠道微生态。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Aug 1;51(4):438-453. doi: 10.3724/zdxbyxb-2022-0283.
3
The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.肝细胞癌的肿瘤内细菌分类群特征。
Microbiol Spectr. 2022 Oct 26;10(5):e0098322. doi: 10.1128/spectrum.00983-22. Epub 2022 Sep 29.
4
Ascitic microbiota alteration is associated with portal vein tumor thrombosis occurrence and prognosis in hepatocellular carcinoma.腹水微生物组的改变与肝癌门静脉癌栓的发生和预后相关。
mBio. 2024 May 8;15(5):e0024524. doi: 10.1128/mbio.00245-24. Epub 2024 Apr 2.
5
The intrahepatic bacterial metataxonomic signature of patients with hepatocellular carcinoma.肝癌患者的肝内细菌分类群特征。
Sci Rep. 2024 Nov 23;14(1):29077. doi: 10.1038/s41598-024-80246-z.
6
Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues.人类肝细胞癌及相邻非肿瘤组织中的微生物特征概述。
J Transl Med. 2023 Feb 2;21(1):68. doi: 10.1186/s12967-023-03938-6.
7
Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery.肿瘤内微生物组可预测肝癌手术后的预后。
Clin Transl Med. 2023 Jul;13(7):e1331. doi: 10.1002/ctm2.1331.
8
Altitude-adaption of gut microbiota in Tibetan chicken.藏鸡肠道微生物菌群的高原适应
Poult Sci. 2022 Sep;101(9):101998. doi: 10.1016/j.psj.2022.101998. Epub 2022 Jun 10.
9
Effect of Drought Stress and Developmental Stages on Microbial Community Structure and Diversity in Peanut Rhizosphere Soil.干旱胁迫和发育阶段对花生根际土壤微生物群落结构和多样性的影响。
Int J Mol Sci. 2019 May 8;20(9):2265. doi: 10.3390/ijms20092265.
10
Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.基于宏基因组学的非酒精性脂肪性肝病患者结肠黏膜活检样本肠道微生物菌群分布分析
Gene. 2022 Jul 30;833:146587. doi: 10.1016/j.gene.2022.146587. Epub 2022 May 19.

引用本文的文献

1
Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer.了解肠道和肝脏微生物群之间的串扰:肝癌的发病机制与治疗方法
Cancer Cell Int. 2025 Jul 29;25(1):291. doi: 10.1186/s12935-025-03840-9.
2
Intratumor sp. drives DEN-induced hepatocellular carcinoma progression by modulating gut microbiota and angiogenesis.肿瘤内特定菌种通过调节肠道微生物群和血管生成驱动二乙基亚硝胺诱导的肝细胞癌进展。
Curr Res Microb Sci. 2025 Jun 24;9:100428. doi: 10.1016/j.crmicr.2025.100428. eCollection 2025.
3
The multifaceted role of microbiota in liver cancer: pathogenesis, therapy, prognosis, and immunotherapy.
微生物群在肝癌中的多方面作用:发病机制、治疗、预后及免疫治疗
Front Immunol. 2025 Jun 16;16:1575963. doi: 10.3389/fimmu.2025.1575963. eCollection 2025.
4
The Gut Microbiome in Hepatocellular Carcinoma: Proliferation, Inhibition, Diagnosis, and Immunotherapy.肝细胞癌中的肠道微生物群:增殖、抑制、诊断与免疫治疗
J Microbiol Biotechnol. 2025 May 15;35:e2412075. doi: 10.4014/jmb.2412.12075.
5
Relevance of oncobiome in breast cancer evolution in an Argentine cohort.阿根廷队列中肿瘤微生物群在乳腺癌进展中的相关性
mSphere. 2025 Mar 25;10(3):e0059724. doi: 10.1128/msphere.00597-24. Epub 2025 Feb 10.
6
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma.肝细胞癌瘤内微生物研究进展
J Hepatocell Carcinoma. 2025 Jan 18;12:59-76. doi: 10.2147/JHC.S496964. eCollection 2025.
7
Gut microbiota characteristics of colorectal cancer patients in Hubei, China, and differences with cohorts from other Chinese regions.中国湖北地区结直肠癌患者的肠道微生物群特征及其与中国其他地区队列的差异。
Front Microbiol. 2024 Jun 19;15:1395514. doi: 10.3389/fmicb.2024.1395514. eCollection 2024.
8
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.基线肠道微生物群作为预测早期乳腺癌患者新辅助化疗疗效的标志物:在濑户内海乳腺癌项目-14 中的一项多中心前瞻性队列研究。
Breast Cancer Res Treat. 2024 Nov;208(1):67-77. doi: 10.1007/s10549-024-07395-7. Epub 2024 Jun 18.